Image-01 (Image 01)
Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 71335-2495
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 71335-2495). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image-02 (Image 02)
This appears to be a list of special population scenarios related to hepatocellular impairment, renal insufficiency, age over 80 years, gender differences, and pharmacokinetics. The text mentions the impact of CYP2D6 polymorphism on metabolization; variations in analyte levels related to venlafaxine; and fold change with a 90% confidence interval. This information may be used for determining appropriate dosing or management in these specific populations.*
Image-03 (Image 03)
This text appears to provide information on the effects of various drugs on the pharmacokinetics (PK) of venlafaxine. It includes fold change values and 90% confidence intervals for drugs such as ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium when interacting with venlafaxine. The data seems to compare parameters like Cmax (maximum plasma concentration) and AUC (area under the curve) between different drug combinations, potentially in different metabolic types (e.g., CYP2D6 EM's, CYP2DS PM's). The text also includes reference values for interpretation.*
Image-04 (Image 04)
This text appears to be a list of various drug names and analytes, including interactions between them. The list contains names such as Diazepam, Alprazolam, Metoprolol, Risperidone, Imipramine, Haloperidol, Caffeine, Tolbutamide, and Lithium. It also mentions fold change and 90% CI related to these substances. The document seems to be related to drug interactions and analytical measurements.*
Label (Lbl713352495)
Each extended-release capsule contains 150 mg of Venlafaxine Hydrochloride, USP. It is essential to store the medication in a tight, light-resistant container and keep it tightly closed. The capsules should be stored at 20° to 25°C (68° to 77°F), with excursions permitted to 15° to 30°C (59° to 86°F). It is crucial to keep this medication and all drugs out of the reach of children. This prescription is for adult use only. Ensure to dispense the Medication Guide to each patient. Manufacturer: Bryant Ranch Prepack, Inc. Repackaged by: Teva Pharmaceuticals USA.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
